HVTN Research and Mentorship Program (RAMP) Scholar Program for African-American and Latino/a Medical Students
Applications for 2015-2016 have closed. Please check the site in October 2015 for information about the next round of applications, or email Jenna Udren, RAMP Coordinator (email@example.com) to be notified when applications are open.
The HIV Vaccine Trials Network, in collaboration with the National Institute of Mental Health and the National Institute of Allergy and Infectious Diseases, is investing in the next generation of HIV prevention researchers by providing African American and Latino/a medical students with opportunities for independent research along with structured mentoring, project and salary funding, training, and professional development activities.
Grant recipients will work under the mentorship of HVTN-affiliated investigators to conduct research projects in areas of basic, clinical, behavioral and social science. Projects can be:
Short-Term: 2-4 months
- Can be timed with a summer break or fourth year research elective
- Travel to an HIV Vaccine Trials Unit in the US or abroad
- Attend and present at an HVTN Conference
- Maximum award of $20,000
Long-Term: 9-12 months
- Research at an HIV Vaccine Trials Unit in the US with up to 16 weeks at an international HIV Vaccine Trials Unit
- Can be timed with a planned Master's or doctoral program, or be a distinct, non-degree associated research-focused year
- Attend two scientific conferences, including presenting at the HVTN conference
- Maximum award of $60,000
RAMP scholars are funded to travel to an HVTN clinical research site to conduct a project under the mentorship of an investigator.
Project ideas include, but are not limited to:
- Understanding the impact of injection drug use on B cell function.
- Examining the barriers to and facilitators of participation of transmen in preventive HIV vaccine clinical trials.
- Investigating the differences between sexual and behavioral risk data collected via sexual diaries and online survey questionnaire among at-risk HIV-negative men who have sex with men in New York City.
- Quantitating the frequency of HIV-specific public TCR clonotypes in HIV infected individuals and HIV-negative vaccine recipients.
To see projects of our current and former scholars, check out their profiles.
Who can apply?
The HVTN will be accepting up to 8 RAMP scholars that meet the following criteria:
- Self-identify as African-American and/or Latino/a
- Student at US-based medical school
- US citizen or US permanent resident
- Interested in pursuing a future career in HIV vaccine development or HIV prevention research
Application materials will be posted in October-November 2015.
For more information and to be connected to an HVTN investigator, please contact:
Jenna Udren, MPH
HIV Vaccine Trials Network
Fred Hutchinson Cancer Research Center
1100 Eastlake Ave., E3-300
Seattle, WA 98109-1024
Office: (206) 667-6712